Twilio is set to replace Amedisys in the S&P MidCap 400 index following UnitedHealth Group's acquisition of Amedisys.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Twilio is set to replace Amedisys in the S&P MidCap 400 index following UnitedHealth Group's acquisition of Amedisys.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Twilio
US technology company
-
S&P Global
American publicly traded corporation, formerly McGraw Hill Financial, Inc
-
UnitedHealth Group
for-profit health care company
Coverage
Newest first; wire copies grouped- PR NewswireTwilio Set to Join S&P MidCap 400 NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE: TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trad